Seletracetam

Seletracetam
	File:Seletracetam.svg
	File:Seletracetam3d.png
Clinical data
Routes of; administration	Oral
Legal status
Legal status	Unscheduled (US);
Pharmacokinetic data
Bioavailability	>90%
Elimination half-life	8h
Identifiers
	IUPAC name (2S)-2-[(4R)-4-(2,2-difluoroethenyl) -2-oxo-pyrrolidin-1-yl]butanamide;
PubChem CID	9942725;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C10H14F2N2O
Molar mass	232.227
3D model (JSmol)	Interactive image;
	SMILES CCC(C(=O)N)N1CC(CC1=O)C=C(F)F;

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Seletracetam is a drug of the racetam family. It is currently being developed by UCB Pharmaceuticals as an anticonvulsant drug. While similar in structure to so-called nootropic drugs, it is not expected to have cognitive enhancing properties.

Seletracetam

See also

Navigation menu

Clinical data
File:Seletracetam.svg
File:Seletracetam3d.png
Routes of administration	Oral
Legal status
Legal status	Unscheduled (US)
Pharmacokinetic data
Bioavailability	>90%
Elimination half-life	8h
Identifiers
IUPAC name (2S)-2-[(4R)-4-(2,2-difluoroethenyl) -2-oxo-pyrrolidin-1-yl]butanamide
PubChem CID	9942725
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₁₀H₁₄F₂N₂O
Molar mass	232.227
3D model (JSmol)	Interactive image
SMILES CCC(C(=O)N)N1CC(CC1=O)C=C(F)F